
	Rick Bierly was appointed Chief Financial Officer in March 2014 at Medivation.

	&nbsp;

	Previously he served as an executive director in Ernst &amp; Young&rsquo;s (EY) Financial Accounting Advisory Services practice for life sciences and other clients. From 1999 to 2012, he served in several leadership roles at Johnson &amp; Johnson, including vice president, Skillman NJ Shared Financial Services Center, where he was responsible for a shared services center providing financial accounting services to Johnson and Johnson&rsquo;s US-based operating companies.

	&nbsp;

	He also served as vice president and chief financial officer of Centocor and Ortho Biotech, and prior to that served as executive director, finance, following the acquisition of the Centocor biotechnology business by Johnson and Johnson. From 1997 to 1999 he was at Centocor Diagnostics as vice president and chief financial officer and Centocor as executive director, finance.

	&nbsp;

	From 1995 to 1997 he served as vice president and treasurer of a Aventis-Hoechst start-up joint venture in the blood plasma business. He also worked in senior financial roles at Aventis (1991 to 1995) and SmithKline Beecham (1981 to 1991). He began his career in public accounting at EY.

	&nbsp;

	He holds a Bachelor of Business Administration degree from Pennsylvania State University and is a CPA in PA and NJ.
